The thread of life Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (358)	5/26/2002 3:52:21 AM
From: Icebrg	Read Replies (1) of 1336

Mike Too much cash might be a bad thing, but not enough cash is much, much worse. We will have to wait through this slump and possibly even longer before judging who has been smart and who hasn't. A point in case. Medarex who appears on the list of dumb biotechs with too much cash on their hands and too few ideas in their heads, managed to scoop up Corixa's conjugating technology including linkers, potent toxins and some targets as well as the responsibility to support a further 30 scientists. Corixa on the other hand with a lot of ideas but not enough funds ended up almost empty-handed. No doubt Medarex came out as the winner in that transaction because of the status of their bank accounts. Ice

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next